Trial Profile
Comparison of continuous combined estrogen-progestin regimen in alleviation of estrogen deficiency symptoms of postmenopausal women. A randomized, double-blind, fixed dose, multicentre phase IIIb study of 12 month.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 May 2011
Price :
$35
*
At a glance
- Drugs Estradiol valerate/medroxyprogesterone (Primary)
- Indications Menopausal syndrome
- Focus Therapeutic Use
- Sponsors Orion
- 12 May 2011 New trial record